Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 18, 2019 Filed Apr 22, 2019 20:17 UTC |
Christmas Patrick J.SVP, General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,459 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001562180-19-002324 · primarydocument.xml · derivative · entry 8 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,641 Underlying: Common Stock · 1,459 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 11,100 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 20:17 UTC |
Christmas Patrick J.SVP, General Counsel
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,541 | $0.00 Strike: $12.10 | $0.00 |
DisclosureSEC source: 0001562180-19-002324 · primarydocument.xml · derivative · entry 7 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,931 Underlying: Common Stock · 3,541 shares Expires 2026-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 20:17 UTC |
Christmas Patrick J.SVP, General Counsel
|
SaleCommon Stock | 100 | $55.50 | $5,550.00 |
DisclosureSEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 6 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,006 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 20:17 UTC |
Christmas Patrick J.SVP, General Counsel
|
SaleCommon Stock | 885 | $54.66 | $48,374.10 |
DisclosureSEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 5 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,106 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $54.32 to $55.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 20:17 UTC |
Christmas Patrick J.SVP, General Counsel
|
SaleCommon Stock | 1,115 | $53.67 | $59,842.05 |
DisclosureSEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 4 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,991 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $53.20 to $54.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 20:17 UTC |
Christmas Patrick J.SVP, General Counsel
|
SaleCommon Stock | 2,900 | $52.55 | $152,395.00 |
DisclosureSEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 3 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,106 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $52.12 to $53.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 20:17 UTC |
Christmas Patrick J.SVP, General Counsel
|
Exercise / conversionCommon Stock | 1,459 | $19.50 | $28,450.50 |
DisclosureSEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 2 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 20:17 UTC |
Christmas Patrick J.SVP, General Counsel
|
Exercise / conversionCommon Stock | 3,541 | $12.10 | $42,846.10 |
DisclosureSEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 17, 2019 Filed Apr 19, 2019 20:14 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 95,000 | $0.00 Strike: $54.72 | $0.00 |
DisclosureSEC source: 0001562180-19-002311 · primarydocument.xml · derivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2029-04-17 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following April 17, 2020 while the optionee provides continuous service to the Issuer. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 16:19 UTC |
Danos OlivierChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001562180-19-002295 · primarydocument.xml · derivative · entry 4 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,500 Underlying: Common Stock · 2,000 shares Expires 2027-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 100,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on March 27, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 16:19 UTC |
Danos OlivierChief Scientific Officer
|
SaleCommon Stock | 1,000 | $53.09 | $53,090.00 |
DisclosureSEC source: 0001562180-19-002295 · primarydocument.xml · nonDerivative · entry 3 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $52.94 to $53.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 16:19 UTC |
Danos OlivierChief Scientific Officer
|
SaleCommon Stock | 1,000 | $52.23 | $52,230.00 |
DisclosureSEC source: 0001562180-19-002295 · primarydocument.xml · nonDerivative · entry 2 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $51.88 to $52.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 16:19 UTC |
Danos OlivierChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,000 | $20.35 | $40,700.00 |
DisclosureSEC source: 0001562180-19-002295 · primarydocument.xml · nonDerivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 21, 2019 Filed Mar 25, 2019 12:32 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 1,700 | $61.31 | $104,227.00 |
DisclosureSEC source: 0001562180-19-002018 · primarydocument.xml · nonDerivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,215 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $61.12 to $61.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2019 Filed Mar 25, 2019 12:32 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 8,300 | $60.64 | $503,312.00 |
DisclosureSEC source: 0001562180-19-002018 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,915 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $60.12 to $61.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:17 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-19-002005 · primarydocument.xml · derivative · entry 4 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,670 Underlying: Common Stock · 15,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:17 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 9,130 | $58.74 | $536,296.20 |
DisclosureSEC source: 0001562180-19-002005 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,000 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $58.51 to $59.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:17 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 5,870 | $58.21 | $341,692.70 |
DisclosureSEC source: 0001562180-19-002005 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,130 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $57.51 to $58.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:17 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 15,000 | $0.85 | $12,750.00 |
DisclosureSEC source: 0001562180-19-002005 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 16:17 UTC |
Danos OlivierChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001562180-19-001906 · primarydocument.xml · derivative · entry 2 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,500 Underlying: Common Stock · 5,000 shares Expires 2027-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 100,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on March 27, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 16:17 UTC |
Danos OlivierChief Scientific Officer
|
Exercise / conversionCommon Stock | 5,000 | $20.35 | $101,750.00 |
DisclosureSEC source: 0001562180-19-001906 · primarydocument.xml · nonDerivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 16:23 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 3,068 | $60.01 | $184,110.68 |
DisclosureSEC source: 0001562180-19-001801 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,215 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 22:35 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,300 | $0.00 Strike: $35.80 | $0.00 |
DisclosureSEC source: 0001562180-19-001472 · primarydocument.xml · derivative · entry 3 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,250 Underlying: Common Stock · 5,300 shares Expires 2028-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 22:35 UTC |
Simpson CurranSVP, Product Development & CTO
|
SaleCommon Stock | 5,300 | $54.05 | $286,465.00 |
DisclosureSEC source: 0001562180-19-001472 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,500 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 22:35 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 5,300 | $35.80 | $189,740.00 |
DisclosureSEC source: 0001562180-19-001472 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:19 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 8,066 | $47.84 | $385,877.44 |
DisclosureSEC source: 0001562180-19-001047 · primarydocument.xml · nonDerivative · entry 4 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,000 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $47.57 to $48.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:19 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 3,522 | $47.30 | $166,590.60 |
DisclosureSEC source: 0001562180-19-001047 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,066 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $46.56 to $47.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:19 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 3,412 | $45.96 | $156,815.52 |
DisclosureSEC source: 0001562180-19-001047 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,588 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.48 to $46.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:19 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-19-001047 · primarydocument.xml · derivative · entry 5 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,670 Underlying: Common Stock · 15,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:19 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 15,000 | $0.85 | $12,750.00 |
DisclosureSEC source: 0001562180-19-001047 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 16:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-19-000874 · primarydocument.xml · derivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,900 Underlying: Common Stock · 120,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 424,900 shares, became exercisable as follows: 284,683 of the shares subject to the option are initial shares ("Initial Shares") and 140,217 of the shares subject to the option are contingent shares ("Contingent Shares"). 72,235 of the Initial Shares vested on September 17, 2014, 53,112 of the Initial Shares vested on September 17, 2015 and an additional 4,426 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. F2 · derivative.exercise_date: (Continued from footnote 1) Notwithstanding the foregoing, 59,533 shares subject to this option that would otherwise have vested monthly between January 2018 and September 2018 were deemed vested as of December 31, 2015 on January 28, 2016 due to subsequent events. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 16:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionCommon Stock | 120,000 | $0.85 | $102,000.00 |
DisclosureSEC source: 0001562180-19-000874 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 625 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · derivative · entry 9 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 625 shares Expires 2026-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 10,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,875 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · derivative · entry 8 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 1,875 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 32,882 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · derivative · entry 7 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,219 Underlying: Common Stock · 32,882 shares Expires 2025-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,450 | $0.00 Strike: $35.80 | $0.00 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · derivative · entry 6 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,550 Underlying: Common Stock · 8,450 shares Expires 2028-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
SaleCommon Stock | 43,832 | $50.08 | $2,195,106.56 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 5 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,500 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 625 | $13.09 | $8,181.25 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 4 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 1,875 | $19.50 | $36,562.50 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 3 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 32,882 | $22.00 | $723,404.00 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 8,450 | $35.80 | $302,510.00 |
DisclosureSEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:21 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-19-000759 · primarydocument.xml · derivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,670 Underlying: Common Stock · 45,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:21 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 45,000 | $0.85 | $38,250.00 |
DisclosureSEC source: 0001562180-19-000759 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:18 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 3,140 | $44.40 | $139,416.00 |
DisclosureSEC source: 0001562180-19-000337 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,000 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $44.13 to $44.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:18 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 11,860 | $43.70 | $518,282.00 |
DisclosureSEC source: 0001562180-19-000337 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,140 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.13 to $44.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 16:24 UTC |
Danos OlivierChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $40.82 | $0.00 |
DisclosureSEC source: 0001562180-19-000220 · primarydocument.xml · derivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2029-01-03 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:20 UTC |
Mills Kenneth T.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 190,000 | $0.00 Strike: $40.82 | $0.00 |
DisclosureSEC source: 0001562180-19-000218 · primarydocument.xml · derivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2029-01-03 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 16:23 UTC |
Vasista VittalChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 57,000 | $0.00 Strike: $40.82 | $0.00 |
DisclosureSEC source: 0001562180-19-000219 · primarydocument.xml · derivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 Underlying: Common Stock · 57,000 shares Expires 2029-01-03 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:25 UTC |
Simpson CurranSVP, Product Development & CTO
|
GrantStock Option (Right to Buy) · Derivative | 46,000 | $0.00 Strike: $40.82 | $0.00 |
DisclosureSEC source: 0001562180-19-000221 · primarydocument.xml · derivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 Underlying: Common Stock · 46,000 shares Expires 2029-01-03 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:27 UTC |
Christmas Patrick J.SVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $40.82 | $0.00 |
DisclosureSEC source: 0001562180-19-000222 · primarydocument.xml · derivative · entry 2 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-01-03 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.